ArticleCureus2024

Late-Stage Ovarian Cancer With Systemic Multiple Metastases Shows Marked Shrinkage Using a Combination of Wilms' Tumor Antigen 1 (WT1) Dendritic Cell Vaccine, Natural Killer (NK) Cell Therapy, and Nivolumab.

Hisashi Nagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.